Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anamorelin in NSCLC-Cachexia (ROMANA 2)
NCT01387282Phase 3Completed
- Start
- Jul 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of anamorelin in cancer cachexia. Started Jul 2011; status: completed.
02
Drugs
anamorelin
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT01387282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387282.